Antibody Engineering: Advances From the Use of Escherichia coli Expression Systems
- 1 June 1991
- journal article
- review article
- Published by Springer Nature in Nature Biotechnology
- Vol. 9 (6) , 545-551
- https://doi.org/10.1038/nbt0691-545
Abstract
Synthesis in Escherichia coli of correctly folded antibody fragments that bind antigen with the same affinity as the whole antibody is now possible. Here I review the techniques for achieving this and the physical properties of the various fragments produced. This technology not only facilitates antibody engineering but is also the basis of screening libraries for binding activity. Although the immunization of animals has not been made unnecessary in the production of monoclonal antibodies, steps toward this goal are now feasible.Keywords
This publication has 58 references indexed in Scilit:
- Mapping and modification of an antibody hapten binding site: a site-directed mutagenesis study of McPC603Biochemistry, 1991
- Small rearrangements in structures of Fv and Fab fragments of antibody D 1.3 on antigen bindingNature, 1990
- Antibodies from Escherichia coliNature, 1990
- Crystallization and preliminary X-ray diffraction study of the bacterially expressed Fv from the monoclonal anti-lysozyme antibody D1.3 and of its complex with the antigen, lysozymeJournal of Molecular Biology, 1990
- Crystallization and preliminary X-ray studies of the VL domain of the antibody McPC603 produced in Escherichia coliJournal of Molecular Biology, 1990
- Expression and secretion of aequorin as a chimeric antibody by means of a mammalian expression vector.Proceedings of the National Academy of Sciences, 1990
- A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxinNature, 1989
- Genetically Engineered Antibody MoleculesPublished by Elsevier ,1989
- Recombinant antibodies possessing novel effector functionsNature, 1984
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975